COVID-19 trials registries data warehouse

http://www.chictr.org.cn/showproj.aspx?proj=50421

Chen Chunbo

gghicu@163.com

2020-03-02

Recruiting

RCT

Randomized

Parallel

Blind label

multi-center

Treatment

(1) Patients aged from 18 to 75 years old, (2) Mild patients with confirmed COVID-19 according to the diagnostic criteria of novel coronavirus Infection Diagnosis and Treatment Plan (Trial 6th Edition) issued by the National Health and Safety Commission, (3) Patients and their families voluntarily participated in the study and signed an informed consent form.

(1) Female patients during pregnancy or lactation, (2) Patients allergic to lipoic acid or similar drugs (B vitamins), previously intolerant to the recommended dose of lipoic acid, (3) Patients who are taking part in clinical trials of other drugs, (4) Patients are taking other foods or drugs with antioxidant effect, such as vitamin C, vitamin E, etc. (5) Patients with other serious diseases that may threaten life, such as cancer.

2

Maoming People's Hospital

18

75

China

Mild disease at enrollment

1: Mild disease at enrollment

394

Progression rate from mild to critical/severe;

| Declared number of arm (2.0) differs from found arms (3.0)

Phase 4

[{"arm_notes": "", "treatment_id": 70, "treatment_name": "Alpha lipoic acid", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]